Web stats for Buscopan-plus - buscopan-plus.de
Buscopan Nummer 1 weltweit - zielgenau den Bauchschmerz behandeln
Traffic Report of Buscopan-plus
| Daily Unique Visitors: | 336 |
| Daily Pageviews: | 672 |
Estimated Valuation
| Income Per Day: | $ 2.00 |
| Estimated Worth: | $ 480.00 |
Search Engine Indexes
| Google Indexed Pages: | Not Applicable |
| Yahoo Indexed Pages: | Not Applicable |
| Bing Indexed Pages: | Not Applicable |
Search Engine Backlinks
| Google Backlinks: | Not Applicable |
| Bing Backlinks: | Not Applicable |
Safety Information
| Google Safe Browsing: | No Risk Issues |
| Siteadvisor Rating: | Not Applicable |
| WOT Trustworthiness: | Not Applicable |
| WOT Privacy: | Not Applicable |
| WOT Child Safety: | Not Applicable |
Website Ranks & Scores
| Google Pagerank: |
|
| Alexa Rank: | 1,429,979 |
| Domain Authority: | Not Applicable |
Where is buscopan-plus.de server located?
Social Engagement
| Facebook Shares: | 14 |
| Facebook Likes: | 5 |
| Facebook Comments: | 22 |
Page Resources Breakdown
Homepage Links Analysis
Similar Domain Names
These are similar domain names that may be used for typosquatting or phishing attacks. Always verify the URL before entering any sensitive information.
- bbuscopan-plus.de
- buuscopan-plus.de
- busscopan-plus.de
- busccopan-plus.de
- buscoopan-plus.de
- buscoppan-plus.de
- buscopaan-plus.de
- buscopann-plus.de
- buscopan--plus.de
- buscopan-pplus.de
- buscopan-pllus.de
- buscopan-pluus.de
- buscopan-pluss.de
- uscopan-plus.de
- bscopan-plus.de
Website Inpage Analysis
| H1 Headings: | Not Applicable | H2 Headings: | Not Applicable |
| H3 Headings: | 6 | H4 Headings: | Not Applicable |
| H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
| Total IFRAMEs: | Not Applicable | Total Images: | 6 |
| Google Adsense: | Not Applicable | Google Analytics: | UA-36776748-1 |
Websites Hosted on Same IP (i.e. 94.100.253.195)
Boehringer Ingelheim - researching, developing, manufacturing and marketing of pharmaceuticals
Boehringer Ingelheim ranks among the world's leading pharmaceutical companies, focusing on prescription medicines, consumer health care, chemicals, biopharmaceuticals and animal health.
Boehringer Ingelheim erforscht, entwickelt, produziert und vermarktet Arzneimittel
Boehringer Ingelheim schafft Werte durch Innovationen. Besonderes Augenmerk liegt dabei auf der Entwicklung fortschrittlicher Arzneimittel, die eine bessere Versorgung für Patienten ermöglichen. Boehringer Ingelheim gehört heute international zu den forschungsintensivsten Unternehmen.
ベーリンガーインゲルハイム
ベーリンガーインゲルハイムは1885年以来、常に成功を収めてきた研究開発主導型の外資系製薬会社です。株式を公開しない企業形態の特色を生かして長期に持続的で着実な成長を目指します。
HTTP Header Analysis
Status-Code: 200
Status: 200 OK
Date: Sat, 11 Apr 2015 08:05:53 GMT
Server: Apache
Last-Modified: Fri, 10 Apr 2015 16:58:20 GMT
Accept-Ranges: bytes
Pragma: no-cache
Cache-Control: no-cache,no-store
Content-Type: text/html; charset=UTF-8
node: Metis
Content-Length: 34578
Domain Information for buscopan-plus.de
Domain Nameserver Information
DNS Record Analysis
| Host | Type | TTL | Extra |
|---|---|---|---|
| buscopan-plus.de | A | 21588 |
IP:94.100.253.195 |
| buscopan-plus.de | NS | 21599 |
Target:obs.ns1.fr |
| buscopan-plus.de | NS | 21599 |
Target:ns2.observatoiredesmarques.fr |
| buscopan-plus.de | NS | 21599 |
Target:ns3.nameshield.net |
| buscopan-plus.de | SOA | 21599 |
MNAME:obs.ns1.fr RNAME:technical.nameshield.net Serial:2014121104 Refresh:28800 Retry:7200 Expire:604800 Minimum TTL:7200 |
| buscopan-plus.de | MX | 21599 |
Target:mail3.boehringer-ingelheim.com |
| buscopan-plus.de | MX | 21599 |
Target:mail4.boehringer-ingelheim.com |
| buscopan-plus.de | MX | 21599 |
Target:mail1.boehringer-ingelheim.com |
| buscopan-plus.de | MX | 21599 |
Target:mail2.boehringer-ingelheim.com |
Similarly Ranked Websites to Buscopan-plus
Close-Up.it - storie della visione
Close-Up.it - rivista e magazine di cinema, teatro e musica con recensioni, forum, blog - diretta da Giovanni Spagnoletti
Seabridge Gold :: Home
Seabridgegold is one of North America's fastest growing gold and copper companies. leverage to gold, gold ownership, growth in resources investing in stocks
Netherlands
United States
France